37.24
price down icon2.05%   -0.78
after-market 시간 외 거래: 37.30 0.06 +0.16%
loading
전일 마감가:
$38.02
열려 있는:
$37.82
하루 거래량:
522.50K
Relative Volume:
1.33
시가총액:
$1.87B
수익:
$345.60M
순이익/손실:
$-79.01M
주가수익비율:
-23.21
EPS:
-1.6045
순현금흐름:
$-18.62M
1주 성능:
+1.75%
1개월 성능:
+32.72%
6개월 성능:
+18.15%
1년 성능:
-12.77%
1일 변동 폭
Value
$37.08
$38.60
1주일 범위
Value
$36.65
$39.33
52주 변동 폭
Value
$23.15
$43.12

이뮤노코어 홀딩스 Stock (IMCR) Company Profile

Name
명칭
Immunocore Holdings Plc Adr
Name
전화
01235 5430281
Name
주소
90 PARK DRIVE, OXFORDSHIRE
Name
직원
493
Name
트위터
Name
다음 수익 날짜
2024-11-05
Name
최신 SEC 제출 서류
Name
IMCR's Discussions on Twitter

IMCR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IMCR
Immunocore Holdings Plc Adr
37.24 1.76B 345.60M -79.01M -18.62M -1.6045
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.232 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.34 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 65.36B 14.09B 4.50B 2.96B 39.28

이뮤노코어 홀딩스 Stock (IMCR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-27 개시 Deutsche Bank Buy
2024-12-13 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2024-11-11 다운그레이드 Mizuho Outperform → Neutral
2024-10-24 개시 UBS Sell
2024-10-07 다운그레이드 Guggenheim Buy → Neutral
2024-04-29 개시 Leerink Partners Outperform
2023-11-20 재개 JP Morgan Overweight
2023-11-02 개시 Cantor Fitzgerald Overweight
2023-10-31 개시 Robert W. Baird Outperform
2023-09-13 업그레이드 JP Morgan Neutral → Overweight
2023-09-13 개시 Needham Buy
2023-08-16 개시 CapitalOne Overweight
2023-07-17 개시 Canaccord Genuity Hold
2023-03-31 개시 Mizuho Buy
2023-03-30 개시 Guggenheim Buy
2023-03-24 개시 Bryan Garnier Buy
2022-12-16 업그레이드 Goldman Neutral → Buy
2022-11-30 개시 Barclays Overweight
2022-09-09 개시 Morgan Stanley Overweight
2022-09-08 개시 Ladenburg Thalmann Buy
2022-08-08 개시 Cowen Outperform
2022-08-02 개시 BTIG Research Buy
2022-02-08 개시 H.C. Wainwright Buy
2021-10-20 개시 Oppenheimer Outperform
2021-03-02 개시 Goldman Neutral
2021-03-02 개시 JP Morgan Overweight
2021-03-02 개시 Jefferies Buy
모두보기

이뮤노코어 홀딩스 주식(IMCR)의 최신 뉴스

pulisher
Jun 05, 2025

Immunocore at Jefferies Global Healthcare Conference: Strong Growth and Promising Trials - Investing.com India

Jun 05, 2025
pulisher
Jun 02, 2025

Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet - sharewise

Jun 02, 2025
pulisher
May 27, 2025

Deutsche Bank sets $65 target on Immunocore stock, rates Buy By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Deutsche Bank sets $65 target on Immunocore stock, rates Buy - Investing.com

May 27, 2025
pulisher
May 25, 2025

Immunocore’s SWOT analysis: biotech firm’s stock faces challenges amid growth - Investing.com

May 25, 2025
pulisher
May 24, 2025

Is it a Good Idea to Invest in Immunocore Stock Right Now? - MSN

May 24, 2025
pulisher
May 17, 2025

Wall Street Analysts See an 114.35% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - MSN

May 17, 2025
pulisher
May 09, 2025

Balance Sheet Dive: Hippo Holdings Inc (HIPO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Analyzing Ratios: Symbotic Inc (SYM)’s Financial Story Unveiled - DWinneX

May 09, 2025
pulisher
May 08, 2025

New Strong Buy Stocks for May 8th - The Globe and Mail

May 08, 2025
pulisher
May 07, 2025

Immunocore stock rises as Q1 results top estimates By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
May 07, 2025

Immunocore stock rises as Q1 results top estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Immunocore Holdings earnings beat by $0.49, revenue topped estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

ESPR's Q1 Earnings Miss Estimates, Revenues Beat, Stock Down - Barchart.com

May 06, 2025
pulisher
May 06, 2025

AXSM Q1 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y - The Globe and Mail

May 06, 2025
pulisher
May 02, 2025

Agios' Q1 Loss Narrower Than Expected, Revenues Lag Estimates - Barchart.com

May 02, 2025
pulisher
Apr 30, 2025

Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y - Barchart.com

Apr 30, 2025
pulisher
Apr 30, 2025

Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet - Yahoo Finance

Apr 30, 2025
pulisher
Apr 07, 2025

Mizuho cuts Immunocore stock price target to $33 from $38 - Investing.com

Apr 07, 2025
pulisher
Apr 04, 2025

Immunocore stock hits 52-week low at $27.19 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Immunocore stock hits 52-week low at $27.19 amid market challenges - Investing.com

Apr 04, 2025
pulisher
Mar 28, 2025

Do investors need to be concerned about Immunocore Holdings plc ADR (IMCR)? - US Post News

Mar 28, 2025
pulisher
Mar 22, 2025

Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last? - MSN

Mar 22, 2025
pulisher
Mar 19, 2025

Immunocore holdings sees $23.99 million in stock purchases by Baker Bros - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 17, 2025

Immunocore amends senior notes indenture, files prospectus - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

Immunocore amends senior notes indenture, files prospectus By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 12, 2025

H.C. Wainwright maintains $100 target on Immunocore stock - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Immunocore’s SWOT analysis: biotech firm’s stock outlook amid HIV and cancer drug progress - Investing.com

Mar 12, 2025
pulisher
Mar 11, 2025

BTIG maintains Immunocore stock Buy rating, $91 target - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Immunocore stock hits 52-week low at $27.59 amid market challenges - Investing.com

Mar 11, 2025
pulisher
Mar 10, 2025

Immunocore reports promising HIV trial results By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Immunocore reports promising HIV trial results - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 - GlobeNewswire Inc.

Mar 10, 2025
pulisher
Mar 06, 2025

Immunocore at TD Cowen Conference: Strategic Growth and Innovation - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Immunocore at TD Cowen Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Feb 28, 2025

PBYI Stock Rises as Q4 Earnings & Sales Outpace EstimatesFebruary 28, 2025 - Zacks Investment Research

Feb 28, 2025
pulisher
Feb 26, 2025

Earnings call transcript: Immunocore Holdings Q4 2024 misses EPS - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

Immunocore Holdings earnings missed by $0.23, revenue fell short of estimates - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

United Therapeutics Stock Down Despite Q4 Earnings & Sales Beat - Yahoo Finance

Feb 26, 2025
pulisher
Feb 20, 2025

Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales - Yahoo Finance

Feb 20, 2025
pulisher
Feb 18, 2025

Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store? - MSN

Feb 18, 2025
pulisher
Feb 17, 2025

A stock that deserves closer examination: Empresa Distribuidora y Comercial Norte S.A. ADR (EDN) - US Post News

Feb 17, 2025
pulisher
Feb 17, 2025

I-Mab ADR (IMAB) stock analysis: A simple moving average approach - US Post News

Feb 17, 2025
pulisher
Feb 17, 2025

A closer look at Inhibrx Biosciences Inc (INBX)’s stock price trends - US Post News

Feb 17, 2025

이뮤노코어 홀딩스 (IMCR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.15
price up icon 0.00%
$585.93
price up icon 0.92%
$300.83
price down icon 2.33%
$38.11
price up icon 4.29%
$4.73
price down icon 1.69%
$493.22
price up icon 2.10%
자본화:     |  볼륨(24시간):